- Home
- PYPD vs ALUR Comparison
PYPD vs ALUR Comparison
Compare PYPD & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- ALUR
- Stock Information
- Founded
- PYPD 2008
- ALUR 2009
- Country
- PYPD Israel
- ALUR United States
- Employees
- PYPD N/A
- ALUR 24
- Industry
- PYPD Medical/Dental Instruments
- ALUR
- Sector
- PYPD Health Care
- ALUR
- Exchange
- PYPD Nasdaq
- ALUR Nasdaq
- Market Cap
- PYPD 30.1M
- ALUR 19.1M
- IPO Year
- PYPD 2020
- ALUR N/A
- Fundamental
- Price
- PYPD $2.75
- ALUR $3.32
- Analyst Decision
- PYPD Strong Buy
- ALUR Strong Buy
- Analyst Count
- PYPD 2
- ALUR 3
- Target Price
- PYPD $10.50
- ALUR $22.83
- AVG Volume (30 Days)
- PYPD 14.1K
- ALUR 4.1M
- Earning Date
- PYPD 05-07-2025
- ALUR 03-26-2025
- Dividend Yield
- PYPD N/A
- ALUR N/A
- EPS Growth
- PYPD N/A
- ALUR N/A
- EPS
- PYPD N/A
- ALUR N/A
- Revenue
- PYPD N/A
- ALUR $32,110,000.00
- Revenue This Year
- PYPD N/A
- ALUR $2.18
- Revenue Next Year
- PYPD N/A
- ALUR $35.85
- P/E Ratio
- PYPD N/A
- ALUR N/A
- Revenue Growth
- PYPD N/A
- ALUR N/A
- 52 Week Low
- PYPD $2.37
- ALUR $2.15
- 52 Week High
- PYPD $5.09
- ALUR $98.75
- Technical
- Relative Strength Index (RSI)
- PYPD 42.15
- ALUR 48.28
- Support Level
- PYPD $2.66
- ALUR $2.72
- Resistance Level
- PYPD $2.97
- ALUR $3.50
- Average True Range (ATR)
- PYPD 0.14
- ALUR 0.38
- MACD
- PYPD -0.02
- ALUR 0.17
- Stochastic Oscillator
- PYPD 8.86
- ALUR 47.67
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.